Market Tracker

12/09 5:16pm ET

Arbutus Biopharma Corp (NASDAQ:ABUS)

3.25
Delayed Data
As of 3:59pm ET
 +0.10 / +3.17%
Today’s Change
2.45
Today|||52-Week Range
5.48
-26.97%
Year-to-Date
Should You Get Rid of Emergent BioSolutions (EBS) Now?
10:20am / Zacks.com - Paid Partner Content
Aimmune Closes Enrolment in Phase III Peanut Allergy Study
Nov 30 / Zacks.com - Paid Partner Content
Roche Presents Positive Follicular Lymphoma Data on Gazvya
Dec 06 / Zacks.com - Paid Partner Content
Valeant (VRX) Ups Sales Force to Support Xifaxan/Relistor
Nov 30 / Zacks.com - Paid Partner Content
Pfizer Leukemia Drug Meets Primary Endpoint in Phase III
Dec 06 / Zacks.com - Paid Partner Content
Epizyme Tazemetostat Gets Fast Track Designation in U.S.
Nov 29 / Zacks.com - Paid Partner Content
New Strong Buy Stocks for December 5th
Dec 05 / Zacks.com - Paid Partner Content
Jazz Completes Patient Enrollment in JZP-110 Narcolepsy Trial
Nov 29 / Zacks.com - Paid Partner Content
Foamix Completes Enrolment in Phase III Acne Drug Studies
Nov 30 / Zacks.com - Paid Partner Content
Intellipharmaceutics Submits NDA for Pain Treatment Rexista
Nov 28 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close3.15
Today’s open3.20
Day’s range3.15 - 3.25
Volume322,612
Average volume (3 months)177,181
Market cap$172.7M
Dividend yield--
Data as of 3:59pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)+25.56%
Earnings growth (this year)-151.49%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+66.34%
P/E ratio--
Price/Sales8.13
Price/Book0.31

Competitors

 Today’s
change
Today’s
% change
AGTCApplied Genetic Tech...+0.03+0.26%
TTPHTetraphase Pharmaceu...-0.11-2.38%
OCXOncoCyte Corp+0.05+0.82%
SNDXSyndax Pharmaceutica...-0.45-4.98%
Data as of 4:00pm ET, 12/09/2016

Financials

Next reporting dateMarch 15, 2017
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$24.9M
Annual profit (last year)-$61.1M
Net profit margin-245.73%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Financial Officer &
Executive Vice President
Bruce G. Cousins
Corporate headquarters
Burnaby, British Columbia

Forecasts